Search research articles
Contact Us
Filters
Showing results (21-30 of 79) with videos related to
Page
of 8
Sort By:
Blood Advances
|
April 12, 2021
Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AML
Brian C Shaffer, Jean-Benoit Le Luduec, Soo Park, et al.
Blood Advances
|
March 1, 2024
Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation
Warren B Fingrut, Eric Davis, Anne Archer, et al.
JACC. Cardiooncology
|
February 18, 2026
Atrial Fibrillation Following Autologous Stem Cell Transplantation in Multiple Myeloma: Incidence, Predictors, and Prognostic Impact
Olayiwola Bolaji, Samantha Brown, Brian C Shaffer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 12, 2017
Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia
Bartlomiej M Getta, Mikhail Roshal, Junting Zheng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 10, 2019
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation
Michael Scordo, Meier Hsu, Ann A Jakubowski, et al.
Transplantation and Cellular Therapy
|
October 14, 2021
Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection
Nishi Shah, Parastoo B Dahi, Doris M Ponce, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 29, 2018
Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation
Carlos Rondon-Clavo, Michael Scordo, Patrick Hilden, et al.
Transplantation and Cellular Therapy
|
December 15, 2025
HIGHER HLA-DRB1 EVOLUTIONARY DIVERGENCE (HED) IS ASSOCIATED WITH REDUCED RELAPSE AND IMPROVED SURVIVAL AFTER MATCHED UNRELATED HEMATOPOIETIC CELL TRANSPLANTATION
Jennifer N Saultz, Yung-Tsi Bolon, Tao Wang, et al.
Journal of Geriatric Oncology
|
August 20, 2025
Aging-related, senescence-associated secretory phenotype and allogeneic hematopoietic cell transplantation outcomes in older patients
Mark Y Jeng, Phillip Wong, Jessica R Flynn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 7, 2017
Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection
Satyajit Kosuri, Tara Wolff, Sean M Devlin, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 79) with videos related to
Sort By:
Page
of 8
Blood Advances
|
April 12, 2021
Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AML
Brian C Shaffer, Jean-Benoit Le Luduec, Soo Park, et al.
Blood Advances
|
March 1, 2024
Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation
Warren B Fingrut, Eric Davis, Anne Archer, et al.
JACC. Cardiooncology
|
February 18, 2026
Atrial Fibrillation Following Autologous Stem Cell Transplantation in Multiple Myeloma: Incidence, Predictors, and Prognostic Impact
Olayiwola Bolaji, Samantha Brown, Brian C Shaffer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 12, 2017
Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia
Bartlomiej M Getta, Mikhail Roshal, Junting Zheng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 10, 2019
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation
Michael Scordo, Meier Hsu, Ann A Jakubowski, et al.
Transplantation and Cellular Therapy
|
October 14, 2021
Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection
Nishi Shah, Parastoo B Dahi, Doris M Ponce, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 29, 2018
Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation
Carlos Rondon-Clavo, Michael Scordo, Patrick Hilden, et al.
Transplantation and Cellular Therapy
|
December 15, 2025
HIGHER HLA-DRB1 EVOLUTIONARY DIVERGENCE (HED) IS ASSOCIATED WITH REDUCED RELAPSE AND IMPROVED SURVIVAL AFTER MATCHED UNRELATED HEMATOPOIETIC CELL TRANSPLANTATION
Jennifer N Saultz, Yung-Tsi Bolon, Tao Wang, et al.
Journal of Geriatric Oncology
|
August 20, 2025
Aging-related, senescence-associated secretory phenotype and allogeneic hematopoietic cell transplantation outcomes in older patients
Mark Y Jeng, Phillip Wong, Jessica R Flynn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 7, 2017
Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection
Satyajit Kosuri, Tara Wolff, Sean M Devlin, et al.
Page
of 8